Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:AGL On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAGLagilon health$2.15+2.4%$3.57$1.50▼$7.73$890.00M0.144.97 million shs1.89 million shs7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAGLagilon health+2.58%-3.15%-36.67%-38.48%-68.52%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAGLagilon health2.2535 of 5 stars4.12.00.00.02.30.00.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAGLagilon health 2.17Hold$4.79122.59% UpsideCurrent Analyst Ratings BreakdownLatest DXRX, AGL, YGEN, and ABDX Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/13/2025AGLagilon healthWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$6.00 ➝ $5.005/8/2025AGLagilon healthBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetUnderweight ➝ Underweight$2.00 ➝ $3.005/8/2025AGLagilon healthThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$2.50 ➝ $5.004/28/2025AGLagilon healthJMP SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingMarket Perform ➝ Market Perform4/25/2025AGLagilon healthCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeNeutral ➝ Buy$3.25 ➝ $5.004/15/2025AGLagilon healthCowenSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingHold ➝ Hold4/15/2025AGLagilon healthTD CowenSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetHold ➝ Hold$3.50 ➝ $6.004/15/2025AGLagilon healthRobert W. BairdSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$6.00 ➝ $5.004/8/2025AGLagilon healthSanford C. BernsteinSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeMarket Perform ➝ Outperform$3.30 ➝ $8.503/21/2025AGLagilon healthNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingHold ➝ Hold(Data available from 6/7/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAGLagilon health$5.99B0.15N/AN/A$1.63 per share1.32Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAGLagilon health-$262.60M-$0.59N/AN/AN/A-6.88%-47.84%-14.97%8/5/2025 (Estimated)Latest DXRX, AGL, YGEN, and ABDX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/6/2025Q1 2025AGLagilon health-$0.01$0.03+$0.04$0.03$1.50 billion$1.53 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAGLagilon health$1.8083.72%N/AN/A N/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAGLagilon health0.061.291.29Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAGLagilon healthN/AInsider OwnershipCompanyInsider OwnershipAGLagilon health3.57%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAGLagilon health650413.95 million398.83 millionNot OptionableDXRX, AGL, YGEN, and ABDX HeadlinesRecent News About These CompaniesNuveen Asset Management LLC Sells 953,074 Shares of agilon health, inc. (NYSE:AGL)June 4 at 3:36 AM | marketbeat.comagilon health, inc. (NYSE:AGL) Shares Purchased by Two Sigma Investments LPJune 3, 2025 | marketbeat.comTwo Sigma Advisers LP Increases Stake in agilon health, inc. (NYSE:AGL)June 2, 2025 | marketbeat.comagilon health (NYSE:AGL) Trading 3.8% Higher - Here's What HappenedMay 30, 2025 | marketbeat.comagilon health (NYSE:AGL) Trading Down 2.8% - Here's What HappenedMay 30, 2025 | marketbeat.comBank of America Corp DE Has $6.27 Million Stock Holdings in agilon health, inc. (NYSE:AGL)May 28, 2025 | marketbeat.comAgilon Health’s SWOT analysis: stock faces headwinds amid profitability pushMay 28, 2025 | uk.investing.comagilon health, inc. (NYSE:AGL) Receives Consensus Rating of "Hold" from AnalystsMay 26, 2025 | marketbeat.com404,299 Shares in agilon health, inc. (NYSE:AGL) Bought by Point72 Asset Management L.P.May 25, 2025 | marketbeat.comMillennium Management LLC Purchases 4,706,357 Shares of agilon health, inc. (NYSE:AGL)May 25, 2025 | marketbeat.comDeutsche Bank AG Has $2.29 Million Stake in agilon health, inc. (NYSE:AGL)May 25, 2025 | marketbeat.comBNP Paribas Financial Markets Makes New Investment in agilon health, inc. (NYSE:AGL)May 25, 2025 | marketbeat.comNorthern Trust Corp Has $5.63 Million Stock Holdings in agilon health, inc. (NYSE:AGL)May 23, 2025 | marketbeat.comagilon health to Participate in Bernstein's 41st Annual Strategic Decisions ConferenceMay 19, 2025 | gurufocus.comagilon health to Participate in Bernstein's 41st Annual Strategic Decisions ConferenceMay 19, 2025 | businesswire.comPrice T Rowe Associates Inc. MD Purchases 98,377 Shares of agilon health, inc. (NYSE:AGL)May 15, 2025 | marketbeat.comagilon health Q2 EPS Estimate Reduced by Leerink PartnrsMay 13, 2025 | marketbeat.com2 Healthcare Stocks with Promising Prospects and 1 to Think Twice AboutMay 12, 2025 | finance.yahoo.comHsbc Holdings PLC Purchases 89,407 Shares of agilon health, inc. (NYSE:AGL)May 12, 2025 | marketbeat.comWilliam Blair Has Positive View of agilon health Q1 EarningsMay 10, 2025 | marketbeat.comagilon health (NYSE:AGL) Shares Gap Up After Earnings BeatMay 9, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeDXRX, AGL, YGEN, and ABDX Company Descriptionsagilon health NYSE:AGL$2.15 +0.05 (+2.38%) Closing price 06/6/2025 03:59 PM EasternExtended Trading$2.17 +0.02 (+1.16%) As of 06/6/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 06/02 - 06/06 This Banking Giant Just Got a $90 Price Target Upgrade Broadcom Slides on Solid Earnings, AI Outlook Still Strong The Market’s Silent Warning: What Bonds and Gold Reveal MongoDB Affirms Outlook and Accelerates Stock Price Reversal Are NVIDIA's Ethernet Wins Signs of Hope or Horror for Arista? AT&T: Is This Telecom Giant a Buy or a Bye for Your Portfolio? Why Visa's Innovation Engine Keeps It a Top Portfolio Pick Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
